on 05 Dec 2023
Last Applicant/ Owned by
Route 757, Geert Grooteplein Zuid 10
Nijmegen
NL
6525GA
Serial Number
90873410 filed on 09th Aug 2021
Registration Number
N/A
Filing Basis
1. intent to use
Disclaimer
NO DATA
scientific and technological research in the field of immunoimaging and immunotherapy to provide T-cell engaging biologics or preparations for imaging or drug conjugates based on antibodies, antibody fragments, peptides, nanoparticle polymers or nanoparticle liposomes, or radiolabeled antibodies for nuclear imaging or therapy, or to provide preparations for medical diagnostics; scientific and techRead More
scientific and technological research in the field of immunoimaging and immunotherapy to provide T-cell engaging biologics or preparations for imaging or drug conjugates based on antibodies, antibody fragments, peptides, nanoparticle polymers or nanoparticle liposomes, or radiolabeled antibodies for nuclear imaging or therapy, or to provide preparations for medical diagnostics; scientific and technological research, in the field of imaging or immunotherapy to provide immune-cell engaging biologics or preparations for imaging or drug conjugates based on biologics for therapy, namely, antibodies, antibody fragments, peptides, or small molecules, nanoparticle polymers or nanoparticle liposomes, or radiolabelled antibodies, biologics, peptides and small molecules for nuclear imaging or therapy, or to provide preparations for medical diagnostics
pharmaceutical and veterinary preparations, namely, T-cell engaging biologics or drug conjugates based on biologics for therapy, biologics for immunoimaging, immunotherapy; pharmaceutical and veterinary preparations, namely, antibodies, antibody fragments, peptides or small molecules for immunotherapy treatment; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, or antibodies modified with a chemical tag or a radiolabeled chemical tag, for nuclear imaging or therapy; pharmaceutical preparations for treatment or prevention of cancer, autoimmune or infectious disease; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease; sanitary preparations for medical purposes; biopharmaceutical preparations for use in human and veterinary medicine for treatment of cancer, autoimmune diseases and infectious diseases; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemicals and biological substances for medical use, namely, diagnostic reagents; pharmaceutical and veterinary preparations, namely, immune cell engaging biologics, preparations for imaging, prodrugs, or drug conjugates based on biologics for therapy, biologics, peptides or small molecules for radiotherapy, immunotherapy or chemotherapy; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, biologics, peptides, or small molecules modified with a chemical tag or linker or a radiolabelled chemical tag, for nuclear imaging or therapy; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags or linkers conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease
chemical preparations for use in industry and science; chemical preparations and kits comprised of chemical preparations, for use in modifying or isolating biological materials; chemical preparations for solid phase chemistry or separation technology, such as coated polymers, in bead or resin form, for use in manufacturing
No 90873410
No Service Mark
No REDL-209B
No
No
Yes
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 04th Dec 2023 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 19th Sep 2023 | CORRECTED NOA E-MAILED |
| 18th Sep 2023 | NOTICE OF ALLOWANCE CORRECTION ENTERED |
| 23rd Aug 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 23rd Aug 2023 | NOTICE OF ALLOWANCE CANCELLED |
| 10th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th Jun 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 16th Jun 2023 | SOU TEAS EXTENSION RECEIVED |
| 16th Jun 2023 | SOU EXTENSION 1 FILED |
| 16th Jun 2023 | SOU EXTENSION 1 GRANTED |
